je.st
news
Tag: copies
Physical copies of Fallout 4 will still require a digital download
2015-10-26 21:05:17| Extremetech
Bethesda has confirmed that physical copies of Fallout 4 aren't very physical at all -- the game will require a significant download through Steam, even if you buy the media.
Tags: download
digital
require
physical
Exclusive: CVS says biotech drug copies may bring price cuts of 40-50 percent
2015-03-12 00:17:28| Biotech - Topix.net
The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health Corp told Reuters. CVS is one of the largest U.S. pharmacy benefit managers and, along with rival Express Scripts, has put unprecedented pressure on global pharmaceutical makers to lower prices for its clients.
Tags: price
bring
drug
percent
Biosimilar copies of blockbuster drug launch in major EU markets
2015-02-25 12:59:55| Biotech - Topix.net
Cheap versions of a top-selling drug for rheumatoid arthritis and Crohn's disease are being launched across major European markets in an important advance for a new type of medicines known as biosimilars. The products from South Korean firm Celltrion and its partners Hospira and Mundipharma will compete with Remicade, the original branded drug from Johnson & Johnson and Merck & Co.
Tags: major
drug
copies
markets
Gilead's India patent snag may spur low-cost Sovaldi copies
2015-01-20 22:41:19| Biotech - Topix.net
The Indian patent office's rejection of a key patent for Gilead Sciences' Hepatitis C treatment Sovaldi may pave the way for more low-cost copies in the country. The New Delhi patent office this week rejected one of the patents for Sovaldi on the grounds that it "lacks novelty" and lacks an inventive step.
Tags: india
copies
patent
spur
Gilead's India Patent Snag May Spur Low-Cost Sovaldi Copies
2015-01-16 02:44:37| Biotech - Topix.net
The Indian patent office's rejection of a key patent for Gilead Sciences' Hepatitis C treatment Sovaldi may pave the way for more low-cost copies in the country. The New Delhi patent office this week rejected one of the patents for Sovaldi on the grounds that it "lacks novelty" and lacks an inventive step.
Tags: india
copies
patent
spur